Stay updated on TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial
Sign up to get notified when there's something new on the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page.

Latest updates to the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page
- Check2 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA sitewide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check16 days agoChange DetectedThe site revision label in the footer changed from v3.7.1 to v3.7.2; the page remains a 403 error screen.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check44 days agoChange DetectedAccess to the study record now shows a 403 Forbidden error, replacing the study details with an access-denied page. The page displays the site header/footer and a 403 message, indicating restricted access rather than the trial content.SummaryDifference18%

- Check65 days agoChange DetectedThe page now shows Revision: v3.6.6 instead of v3.6.5, indicating a minor version update to the page. This reflects a small backend/UI update rather than a substantive change to the study details.SummaryDifference0.1%

Stay in the know with updates to TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page.